Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...
The global Oral Anti-Diabetic Drug market is poised for substantial growth, driven by increasing diabetes cases, advancements ...
Individuals using Ozempic and Wegovy to lose weight are at risk of developing serious health complications if they stop ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...
According to phase 2 study, MariTide achieved significant weight loss in individuals with obesity or overweight, with up to ...
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...
Topline results from the Phase 2a trial of VTX3232 in patients with early Parkinson’s disease expected in H1 2025 Phase 2 trial of VTX3232 in subjects with obesity and cardiometabolic risk factors ...
Insurers, including the state, might consider serving up exercise and cooking classes along with the prescription.